Celldex Therapeutics
CLDX
18,73 €
Share price
-2.50%
Change (1 day)
-51.15%
Change (1 year)
Categories
Operating Margin for Celldex Therapeutics (CLDX)
Operating Margin as of March 2025 (TTM): -2,248.76%
According to Celldex Therapeutics's latest financial reports and stock price the company's current Operating Margin is -2,248.76%. At the end of 2024 the company had an Operating Margin of -2,248.76%.
Operating Margin history for Celldex Therapeutics from 2001 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -2,248.76% | 9.44% |
| 2023 | -2,054.76% | -56.88% |
| 2022 | -4,765.59% | 213.34% |
| 2021 | -1,520.92% | 85.11% |
| 2020 | -821.61% | -42.3% |
| 2019 | -1,423.96% | -10.62% |
| 2018 | -1,593.09% | 73.05% |
| 2017 | -920.61% | -51.39% |
| 2016 | -1,894.05% | -18.4% |
| 2015 | -2,321.11% | -29.51% |
| 2014 | -3,292.81% | 65.99% |
| 2013 | -1,983.70% | 275.85% |
| 2012 | -527.79% | 9.15% |
| 2011 | -483.53% | 8832.41% |
| 2010 | -5.41% | -97.78% |
| 2009 | -244.10% | -61.69% |
| 2008 | -637.08% | -58.85% |
| 2007 | -1,548.01% | -31.28% |
| 2006 | -2,252.48% | 268.75% |
| 2005 | -610.85% | 208.45% |
| 2004 | -198.03% | -21.81% |
| 2003 | -253.27% | 17.67% |
| 2002 | -215.25% | -70.68% |
| 2001 | -734.07% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -30.69% | -98.64% | 🇺🇸 USA |
 | -224.49% | -90.02% | 🇺🇸 USA |
 | -14.09% | -99.37% | 🇺🇸 USA |
 | 13.78% | -100.61% | 🇺🇸 USA |
 | 12.60% | -100.56% | 🇺🇸 USA |
 | 10.93% | -100.49% | 🇬🇧 UK |
 | -556,900.00% | 24,664.76% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.